Business

Oxford BioMedica to Present at Biotech Showcase

Oxford BioMedica to Present at Biotech Showcase.

articleOxford Biomedica PlcJanuary 9, 20144/company/oxford-biomedica-plc/news/oxford-biomedica-to-present-at-biotech-showcase
Oxford BioMedica to Present at Biotech Showcase

About this update from Oxford Biomedica Plc

[{"type":"text","content":"\n \nRNS Number : 2998X Oxford Biomedica PLC 09 January 2014  \n\nOxford BioMedica to Present at Biotech Showcase™ Conference\n  \n \nOxford, UK - 9 January 2014: Oxford BioMedica plc (\"Oxford BioMedica\" or \"the Company\") (LSE: OXB), the leading gene-based biopharmaceutical company, announces that John Dawson, Chief Executive Officer, will present a company overview at the Biotech Showcase™ 2014 Conference in San Francisco, California, on Tuesday, 14 January, 2014 at 3:00 p.m. Pacific Time.\n \n- Ends -\n \n\n\n\n\nFor further information, please contact:\n\n\n \n\n\n\n\n \nOxford BioMedica plc:\nJohn Dawson, Chief Executive Officer\nTim Watts, Chief Financial Officer\n\n\n \nTel: +44 (0)1865 783 000\n\n\n\n\n \nMedia Enquiries:\nMary-Jane Elliott/Emma Thompson/Matthew Neal\nConsilium Strategic Communications\n\n\n \n \nTel: +44 (0)20 7920 2354\n\n\n\n\n \nNote to editors\n \n1. About Oxford BioMedica®\nOxford BioMedica plc (LSE: OXB) is a biopharmaceutical company developing innovative gene-based medicines and therapeutic vaccines that aim to improve the lives of patients with high unmet medical needs. The Company's technology platform includes a highly efficient LentiVector® gene delivery system, which has specific advantages for targeting diseases of the central nervous system and the eye; and a unique tumour antigen (5T4), which is an ideal target for anti-cancer therapy. Through in-house and collaborative research, Oxford BioMedica has a broad pipeline with current partners and licensees including Sanofi, Pfizer, Novartis, GlaxoSmithKline, MolMed, Sigma-Aldrich, Biogen Idec, Emergent BioSolutions, ImaginAb and Immune Design Corp. Further information is available at www.oxfordbiomedica.co.uk and www.oxbsolutions.co.uk.\n \n\nThis information is provided by RNSThe company news service from the London Stock Exchange  END  NRAMMGGMZLKGDZM\n ","length":3337,"tagName":"div"}]

More updates from Oxford Biomedica Plc